I’d like to add the INSURANCE COMPANIES are also very culpable in this. Just because they have a program to help a small number of people get a break on the cost of their EAI shouldn’t let them off the hook. There should be one very reasonable and low price for this drug because of its indication: for the emergency treatment of anaphylaxis . . . .